Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Abundance Wealth Counselors

Abundance Wealth Counselors trimmed its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 1.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 676 shares of the medical instruments supplier’s stock after selling 8 shares during the period. Abundance Wealth Counselors’ holdings in Mettler-Toledo International were worth $827,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Creative Planning lifted its position in shares of Mettler-Toledo International by 12.8% in the second quarter. Creative Planning now owns 2,698 shares of the medical instruments supplier’s stock valued at $3,771,000 after acquiring an additional 306 shares in the last quarter. Sanctuary Advisors LLC purchased a new stake in shares of Mettler-Toledo International during the second quarter worth $500,000. Czech National Bank raised its position in shares of Mettler-Toledo International by 6.2% in the third quarter. Czech National Bank now owns 4,322 shares of the medical instruments supplier’s stock valued at $6,482,000 after buying an additional 252 shares during the last quarter. Park Avenue Securities LLC lifted its stake in shares of Mettler-Toledo International by 13.7% in the third quarter. Park Avenue Securities LLC now owns 299 shares of the medical instruments supplier’s stock worth $448,000 after buying an additional 36 shares in the last quarter. Finally, Quent Capital LLC raised its holdings in Mettler-Toledo International by 6.5% in the 3rd quarter. Quent Capital LLC now owns 245 shares of the medical instruments supplier’s stock valued at $367,000 after acquiring an additional 15 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on MTD. Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Wolfe Research began coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. Robert W. Baird lowered their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Evercore ISI raised shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and upped their price objective for the company from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Finally, Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $1,351.25.

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,365.36 on Friday. The company’s 50-day simple moving average is $1,267.00 and its 200-day simple moving average is $1,343.65. Mettler-Toledo International Inc. has a 1 year low of $1,133.46 and a 1 year high of $1,546.93. The stock has a market capitalization of $28.81 billion, a PE ratio of 36.81, a P/E/G ratio of 4.72 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. On average, sell-side analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Insider Activity

In other news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.